These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 2585222)

  • 1. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
    J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.
    Antoon JW; Goldman JL; Shah SS; Lee B
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution.
    Sibbald C; Putterman E; Micheletti R; Treat J; Castelo-Soccio L
    Pediatr Dermatol; 2020 May; 37(3):461-466. PubMed ID: 32058621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Antoon JW; Goldman JL; Lee B; Schwartz A
    Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.
    Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK
    Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU; Njinaka I; Ehimiyen ET
    Trop Doct; 2010 Jul; 40(3):167-8. PubMed ID: 20555046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
    Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chhipa SA; Masood S; Salarzai Y; Khan QA; Ahmad K; Sajid S
    J Pak Med Assoc; 2015 Jan; 65(1):62-4. PubMed ID: 25831677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens Johnson syndrome and toxic epidermal necrolysis - an Australian analysis of treatment outcomes and mortality.
    Tran AK; Sidhu S
    J Dermatolog Treat; 2019 Nov; 30(7):718-723. PubMed ID: 30632424
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lian BS; Lee HY
    Expert Opin Drug Saf; 2022 Aug; 21(8):1039-1046. PubMed ID: 35878014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 15-year review of pediatric toxic epidermal necrolysis.
    Quirke KP; Beck A; Gamelli RL; Mosier MJ
    J Burn Care Res; 2015; 36(1):130-6. PubMed ID: 25501779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.